Related Experiment Videos
Determining Local-Regional Extension of Prostate Cancer.
1Department of Radiation Oncology, The University of Michigan, Ann Arbor, MI, USA
Seminars in Radiation Oncology
|July 1, 1993
Summary
Evaluating prostate cancer staging involves clinical, radiological, and pathological methods. Imaging techniques like CT, MR, and TRUS evolve, impacting staging accuracy and treatment planning for better prostate cancer outcomes.
Area of Science:
- Urology
- Radiology
- Oncology
Background:
- Prostate cancer staging relies on integrated clinical, radiological, and pathological assessments.
- Recent advancements have significantly altered the landscape of diagnostic and staging procedures.
Purpose of the Study:
- To review the current role of various imaging and surgical procedures in staging prostate cancer.
- To evaluate the utility of computed tomography (CT), magnetic resonance imaging (MR), transrectal ultrasound (TRUS), and lymph node dissection in assessing local and regional disease extent.
Main Methods:
- Review of computed tomography (CT) for local extension and lymphatic metastasis assessment.
- Evaluation of magnetic resonance imaging (MR) and transrectal ultrasound (TRUS) for local disease characterization and biopsy guidance.
- Assessment of traditional and laparoscopic lymph node dissection techniques.
Main Results:
- CT has limited sensitivity for lymphatic metastasis but is useful for radiotherapy planning.
- MR may offer superior local staging compared to TRUS, while TRUS aids in targeted biopsies.
- Laparoscopic lymph node dissection shows comparable results to traditional methods in terms of dissection extent and lymph node yield.
Conclusions:
- Prostate cancer staging is a dynamic process influenced by evolving diagnostic procedures.
- The interpretation and application of staging modalities require continuous re-evaluation to optimize patient management and treatment strategies.